Latest Lorcaserin Stories
On June 27th, 2012, the US FDA is set to decide on new obesity drug Lorcaserin.
In the briefing documents for the May 10th, 2012 meeting of the FDA Advisory Committee, reviewers expressed concerns on safety of Lorcaserin obesity drug.
A panel voted 18 to 4 in favor of approving the new anti-obesity drug Lorcaserin for use on the drug market.
- A person in a secondary role, specifically the second most important character (after the protagonist).